Stefania Petrosino - Search Results

Year	Number of Results
2005	5
2006	7
2007	11
2008	16
2009	19
2010	14
2011	9
2012	5
2013	6
2014	5
2015	5
2016	4
2017	3
2018	3
2019	3
2020	2
2021	1
2022	3
2024	0

1

First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury.

Schiano Moriello A, Roviezzo F, Iannotti FA, Rea G, Allarà M, Camerlingo R, Verde R, Di Marzo V, Petrosino S. Schiano Moriello A, et al. Among authors: petrosino s. Biomolecules. 2022 Dec 24;13(1):33. doi: 10.3390/biom13010033. Biomolecules. 2022. PMID: 36671418 Free PMC article.

2

Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice.

Lama A, Pirozzi C, Severi I, Morgese MG, Senzacqua M, Annunziata C, Comella F, Del Piano F, Schiavone S, Petrosino S, Mollica MP, Diano S, Trabace L, Calignano A, Giordano A, Mattace Raso G, Meli R. Lama A, et al. Among authors: petrosino s. Brain Behav Immun. 2022 May;102:110-123. doi: 10.1016/j.bbi.2022.02.008. Epub 2022 Feb 14. Brain Behav Immun. 2022. PMID: 35176443 Free PMC article.

3

Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint.

Schiano Moriello A, Di Marzo V, Petrosino S. Schiano Moriello A, et al. Among authors: petrosino s. Animals (Basel). 2022 Jan 31;12(3):348. doi: 10.3390/ani12030348. Animals (Basel). 2022. PMID: 35158670 Free PMC article. Review.

4

A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.

Manzo E, Schiano Moriello A, Tinto F, Verde R, Allarà M, De Petrocellis L, Pagano E, Izzo AA, Di Marzo V, Petrosino S. Manzo E, et al. Among authors: petrosino s. Cells. 2021 Feb 20;10(2):450. doi: 10.3390/cells10020450. Cells. 2021. PMID: 33672574 Free PMC article.

5

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.

Petrosino S, Schiano Moriello A. Petrosino S, et al. Int J Mol Sci. 2020 Dec 15;21(24):9526. doi: 10.3390/ijms21249526. Int J Mol Sci. 2020. PMID: 33333772 Free PMC article.

6

Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets.

Fellous T, De Maio F, Kalkan H, Carannante B, Boccella S, Petrosino S, Maione S, Di Marzo V, Iannotti FA. Fellous T, et al. Among authors: petrosino s. Biochem Pharmacol. 2020 May;175:113859. doi: 10.1016/j.bcp.2020.113859. Epub 2020 Feb 14. Biochem Pharmacol. 2020. PMID: 32061773 Free article.

7

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.

Petrosino S, Schiano Moriello A, Verde R, Allarà M, Imperatore R, Ligresti A, Mahmoud AM, Peritore AF, Iannotti FA, Di Marzo V. Petrosino S, et al. J Neuroinflammation. 2019 Dec 26;16(1):274. doi: 10.1186/s12974-019-1671-5. J Neuroinflammation. 2019. PMID: 31878942 Free PMC article.

8

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion.

Impellizzeri D, Siracusa R, Cordaro M, Crupi R, Peritore AF, Gugliandolo E, D'Amico R, Petrosino S, Evangelista M, Di Paola R, Cuzzocrea S. Impellizzeri D, et al. Among authors: petrosino s. Neurobiol Dis. 2019 May;125:77-91. doi: 10.1016/j.nbd.2019.01.007. Epub 2019 Jan 17. Neurobiol Dis. 2019. PMID: 30660740

9

Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease.

Mugnaini C, Rabbito A, Brizzi A, Palombi N, Petrosino S, Verde R, Di Marzo V, Ligresti A, Corelli F. Mugnaini C, et al. Among authors: petrosino s. Eur J Med Chem. 2019 Jan 1;161:239-251. doi: 10.1016/j.ejmech.2018.09.070. Epub 2018 Oct 13. Eur J Med Chem. 2019. PMID: 30359820

10

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.

Petrosino S, Verde R, Vaia M, Allarà M, Iuvone T, Di Marzo V. Petrosino S, et al. J Pharmacol Exp Ther. 2018 Jun;365(3):652-663. doi: 10.1124/jpet.117.244368. Epub 2018 Apr 9. J Pharmacol Exp Ther. 2018. PMID: 29632236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year